PLIANT THERAPEUTICS, INC. - PLRX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G | ADAR1 Capital Management, LLC | 8.9% | 5,509,724 | View |
| Aug 14, 2026 | SCHEDULE 13G | Daniel Schneeberger | 8.9% | 5,509,724 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Citadel Advisors LLC | 2.3% | 1,418,022 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Citadel Advisors Holdings LP | 2.3% | 1,418,022 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Citadel GP LLC | 2.3% | 1,418,022 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Citadel Securities LLC | 1.1% | 673,114 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Citadel Securities Group LP | 1.2% | 725,404 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Citadel Securities GP LLC | 1.2% | 725,404 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Kenneth Griffin | 3.5% | 2,143,426 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.